AME’s 2022 profits grow 26% to SAR 26.7 mln

22/03/2023 Argaam Exclusive

View other reports

AME Company for Medical Supplies posted a 26% rise in 2022 net profit to SAR 26.7 million, from SAR 21.2 million a year earlier.

Financials (M)

Item	2021	2022	Change‬
Revenues	151.39	193.17	27.6 %
Gross Income	69.55	90.28	29.8 %
Operating Income	28.96	29.98	3.5 %
Net Income	21.22	26.68	25.7 %
Average Shares	7.00	7.00	-
EPS (Riyals)	3.03	3.81	25.7 %

The profit growth was driven by an increase of SAR 41.78 million year-on-year (YoY) in net revenue for 2022 (net sales proceeds), as well as a rise of SAR 33.8 million and SAR 8 million in the sales of in medical supplies and devices, respectively.

This surge resulted from the company’s acquisition of a larger market share thanks to its participation in local and international conferences, along with more effort to advertise and market its products.

Current Half Annual Comparison (M)

Compared With The

Item	H2 2021	H2 2022	Change‬
Revenues	81.60	84.82	3.9 %
Gross Income	37.54	41.42	10.3 %
Operating Income	15.70	12.72	(19.0 %)
Net Income	13.72	11.31	(17.6 %)
Average Shares	7.00	7.00	-
EPS (Riyals)	1.96	1.62	(17.6 %)

Item	H1 2022	H2 2022	Change‬
Revenues	108.35	84.82	(21.7 %)
Gross Income	48.86	41.42	(15.2 %)
Operating Income	17.25	12.72	(26.3 %)
Net Income	15.38	11.31	(26.5 %)
Average Shares	7.00	7.00	-
EPS (Riyals)	2.20	1.62	(26.5 %)

Total shareholders’ equity, no minority interest, rose to SAR 107.3 million as of Dec. 31, 2022, compared to SAR 93.4 million in the year-earlier period.

View More Financial Results

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

×